Skip to main content
Signal8

Cutler Adam D.

SEC insider (Form 3/4/5 filer). CIK 0001722673. Chief Financial Officer at Mural Oncology plc (MURA). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 5, 2025. Located in DUBLIN 2, L2.

Companies Cutler Adam D. has filed insider reports for

  • Mural Oncology plc (MURA): Officer, Chief Financial Officer
Cutler Adam D. profile photo

Cutler Adam D.

CIK: 0001722673

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Mural Oncology plc logo
MURA

Mural Oncology plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Dec 5, 2025
    Disposition
    Direct
    99.3K shares-
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Nov 3, 2025
    Sale
    Direct
    7.1K shares at avg. $2.09$15K
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Mar 3, 2025
    Award
    Direct
    35K shares-
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Oct 31, 2024
    Sale
    Direct
    7.4K shares at avg. $3.41$25K

1-4 of 4